nach oben

Erschienen in:

01.11.2007 | Breast Oncology

Intra-operative Sonography: A Valuable Aid During Breast-Conserving Surgery for Occult Breast Cancer

verfasst von: Anton Haid, MD, Michael Knauer, MD, Stephanie Dunzinger, MD, Zerina Jasarevic, MD, Roswitha Köberle-Wührer, MD, Antonius Schuster, MD, Michael Toeppker, MD, Bernhard Haid, MD, Etienne Wenzl, MD, FRCS, Felix Offner, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 11/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

Breast cancer is increasingly detected during an early non-palpable stage. Together with pre-operative marking of the mass, intra-operative imaging provides invaluable clues. This study was designed to evaluate the usefulness of intra-operative sonography in the hands of the surgeon.

Methods

Between July 2001 and October 2006, 567 patients underwent treatment for operable breast cancer at the landeskrankenhaus (LHK) Feldkirch. Three hundred and sixty lesions were not palpable. Two hundred and ninety-nine patients with poorly definable or non-definable lesions well seen by ultrasound imaging underwent intra-operative sonography (group 1), while 61 patients with non-palpable lesions only seen on mammography (group 2) were subjected to pre-operative needle localization.

The study was non-randomized with prospective data acquisition

Results

All lesions were identified by both sonography and pre-operative needle localization. In the ultrasound group (group 1) 81% of the lesions were successfully removed by primary intention without metachronous secondary surgery versus 62% in group 2 (p < 0.00228). Eighty-eight percent of the lesions in group 1 were eligible for breast-conserving surgery versus 75% in group 2. The mean clear margin in group 1 was substantially smaller (4.8 mm) than in group 2 (7.2 mm) (p < 0.0001).

Conclusion

Intra-operative sonography proved to be a reliable and helpful tool in the hands of the surgeon, not only for tumor localization, but also for orientation during tumor excision. It simplifies organizational work and spares the patient the discomfort of pre-operative needle localization.

Duffy SW, Tabar L, Vitak B, et al. The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation. Ann Oncol 2003; 14(8):1196–8

Olsen AH, Njor SH, Vejborg I, et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ 2005; 330(7485):220PubMedCrossRef

Nurko J, Edwards MJ. Image-guided breast surgery. Am J Surg 2005; 190(2):221–7PubMedCrossRef

Gallagher WJ, Cardenosa G, Rubens JR, et al. Minimal-volume excision of nonpalpable breast lesions. AJR Am J Roentgenol 1989; 153(5):957–61PubMed

Buchberger W, Niehoff A, Obrist P, et al. Clinically and mammographically occult breast lesions: detection and classification with high-resolution sonography. Semin Ultrasound CT MR 2000; 21(4):325–36PubMedCrossRef

Buman SJ, Clark DA. Breast intraoperative ultrasound: prospective study in 112 patients with impalpable lesions. ANZ J Surg 2005; 75(3):124–7PubMedCrossRef

Schwartz GF, Goldberg BB, Rifkin MD, D’Orazio SE. Ultrasonography: an alternative to x-ray-guided needle localization of nonpalpable breast masses. Surgery 1988; 104(5):870–3PubMed

di Giorgio A, Arnone P, Canavese A. Ultrasound guided excisional biopsy of non-palpable breast lesions: technique and preliminary results. Eur J Surg 1998; 164(11):819–24PubMedCrossRef

Rahusen FD, Taets van Amerongen AH, van Diest PJ, et al. Ultrasound-guided lumpectomy of nonpalpable breast cancers: A feasibility study looking at the accuracy of obtained margins. J Surg Oncol 1999; 72(2):72–6PubMedCrossRef

10.

Henry-Tillman R, Johnson AT, Smith LF, Klimberg VS. Intraoperative ultrasound and other techniques to achieve negative margins. Semin Surg Oncol 2001; 20(3):206–13PubMedCrossRef

11.

Moore MM, Whitney LA, Cerilli L, et al. Intraoperative ultrasound is associated with clear lumpectomy margins for palpable infiltrating ductal breast cancer. Ann Surg 2001; 233(6):761–8PubMedCrossRef

12.

Kaufman CS, Jacobson L, Bachman B, Kaufman LB. Intraoperative ultrasonography guidance is accurate and efficient according to results in 100 breast cancer patients. Am J Surg 2003; 186(4):378–82PubMedCrossRef

13.

Bennett IC, Greenslade J, Chiam H. Intraoperative ultrasound-guided excision of nonpalpable breast lesions. World J Surg 2005; 29(3):369–74PubMedCrossRef

14.

Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 2005; 16(10):1569–83PubMedCrossRef

15.

Konstantiniuk P KE, Haid A, Bauer C, Steindorfer Peter. Das MCDBP (multi center database project). Acta Chir Austriaca 2001; 33:200–2001

16.

Decker T, Ruhnke M, Schneider W. Standardized pathologic examination of breast excision specimen. Relevance within an interdisciplinary practice protocol for quality management of breast saving therapy. Pathologe 1997; 18(1):53–9PubMedCrossRef

17.

Obrist P, Brunhuber T, Ensinger C, et al. Pathological examination of breast biopsy specimens. Radiologe 2002; 42(1):1–5PubMedCrossRef

18.

Madjar H, Ohlinger R, Mundinger A, et al. BI-RADS-analogue DEGUM criteria for findings in breast ultrasound–consensus of the DEGUM Committee on Breast Ultrasound. Ultraschall Med 2006; 27(4):374–9PubMedCrossRef

19.

Madjar H, Mundinger A, Degenhardt F, et al. Quality control in breast sonography. Ultraschall Med 2003; 24(3):190–4PubMedCrossRef

20.

Buzdar AU, Ibrahim NK, Francis D, et al. Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. J Clin Oncol 2005; 23(16):3676–85PubMedCrossRef

21.

Peintinger F, Symmans WF, Gonzalez-Angulo AM, et al. The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy. Cancer 2006

22.

Nurko J, Mancino AT, Whitacre E, Edwards MJ. Surgical benefits conveyed by biopsy site marking system using ultrasound localization. Am J Surg 2005; 190(4):618–22PubMedCrossRef

23.

Harlow SP, Krag DN, Ames SE, Weaver DL. Intraoperative ultrasound localization to guide surgical excision of nonpalpable breast carcinoma. J Am Coll Surg 1999; 189(3):241–6PubMedCrossRef

24.

Snider HC Jr., Morrison DG. Intraoperative ultrasound localization of nonpalpable breast lesions. Ann Surg Oncol 1999; 6(3):308–14PubMedCrossRef

25.

Smith LF, Rubio IT, Henry-Tillman R, et al. Intraoperative ultrasound-guided breast biopsy. Am J Surg 2000; 180(6):419–23PubMedCrossRef

26.

Arriagada R, Le MG, Rochard F, Contesso G. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol 1996; 14(5):1558–64PubMed

27.

Blichert-Toft M RC, Andersen JA, Overgaard M, Axelsson CK, Andersen KW, Mouridsen HT. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr 1992:19–25

28.

Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347(16):1233–41PubMedCrossRef

29.

van Dongen JA VA, Fentimen IS, Legrand C, Sylvester RJ, Tong D, van der Schueren E, Helle PA, van Zijl K, Bartelink H. Long-term results of a randomized trial comparing breast-conserving therapy with astectomy: European Organization for Research and treatment of Cancer 10801 Trial. J Natl Cancer Inst 2000; 92:1143–50PubMedCrossRef

30.

Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347(16):1227–32PubMedCrossRef

31.

Jacobson JA, Danforth DN, Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 1995; 332(14):907–11PubMedCrossRef

32.

Veronesi U, Marubini E, Del Vecchio M, et al. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst 1995; 87(1):19–27PubMedCrossRef

33.

Smitt MC, Nowels KW, Zdeblick MJ, et al. The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 1995; 76(2):259–67PubMedCrossRef

34.

Klimberg VS, Harms S, Korourian S. Assessing margin status. Surg Oncol 1999; 8(2):77–84PubMedCrossRef

35.

Meric F, Mirza NQ, Vlastos G, et al. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer 2003; 97(4):926–33PubMedCrossRef

36.

Taghian A, Mohiuddin M, Jagsi R, et al. Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg 2005; 241(4):629–39PubMedCrossRef

37.

Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985; 56(5):979–90PubMedCrossRef

38.

Dillon MF, Hill AD, Quinn CM, et al. A pathologic assessment of adequate margin status in breast-conserving therapy. Ann Surg Oncol 2006; 13(3):333–9PubMedCrossRef

39.

Schwartz GF, Veronesi U, Clough KB, et al. Consensus conference on breast conservation, Milan, Italy, April 28-May 1, 2005. Breast J 2006; 12(4):398–407PubMedCrossRef

40.

Greene T, Tartter PI, Smith SR, Estabrook A. The significance of surgical margins for patients with atypical ductal hyperplasia. Am J Surg 2006; 192(4):499–501PubMedCrossRef

41.

Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Cancer 1999; 85(3):616–28PubMedCrossRef

42.

Wong JS. Is radiotherapy boost needed in young patients with ductal carcinoma-in-situ? Lancet Oncol 2006; 7(8):615–7PubMedCrossRef

43.

Singletary SE. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg 2002; 184(5):383–93PubMedCrossRef

44.

Leong C, Boyages J, Jayasinghe UW, et al. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma. Cancer 2004; 100(9):1823–32PubMedCrossRef

45.

Aziz D, Rawlinson E, Narod SA, et al. The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer. Breast J 2006; 12(4):331–7PubMedCrossRef

46.

Swanson GP, Rynearson K, Symmonds R. Significance of margins of excision on breast cancer recurrence. Am J Clin Oncol 2002; 25(5):438–41PubMedCrossRef

47.

Cellini C, Huston TL, Martins D, et al. Multiple re-excisions versus mastectomy in patients with persistent residual disease following breast conservation surgery. Am J Surg 2005; 189(6):662–6PubMedCrossRef

48.

Mendez JE, Lamorte WW, de Las Morenas A, et al. Influence of breast cancer margin assessment method on the rates of positive margins and residual carcinoma. Am J Surg 2006; 192(4):538–40PubMedCrossRef

49.

Kaufman CS, Jacobson L, Bachman B, Kaufman L. Intraoperative ultrasound facilitates surgery for early breast cancer. Ann Surg Oncol 2002; 9(10):988–93PubMedCrossRef

50.

Rahusen FD, Bremers AJ, Fabry HF, et al. Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Ann Surg Oncol 2002; 9(10):994–8PubMed

51.

Gittleman MA. Single-step ultrasound localization of breast lesions and lumpectomy procedure. Am J Surg 2003; 186(4):386–90PubMedCrossRef

52.

Inoue T, Tamaki Y, Sato Y, et al. Three-dimensional ultrasound imaging of breast cancer by a real-time intraoperative navigation system. Breast Cancer 2005; 12(2):122–9PubMedCrossRef

53.

Rifkin MD, Schwartz GF, Pasto ME, et al. Ultrasound for guidance of breast mass removal. J Ultrasound Med 1988; 7(5):261–3PubMed

54.

Paramo JC, Landeros M, McPhee MD, Mesko TW. Intraoperative Ultrasound-Guided Excision of Nonpalpable Breast Lesions. Breast J 1999; 5(6):389–94PubMedCrossRef

55.

Holland R, Connolly JL, Gelman R, et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 1990; 8(1):113–8PubMed

56.

Huston TL, Pigalarga R, Osborne MP, Tousimis E. The influence of additional surgical margins on the total specimen volume excised and the reoperative rate after breast-conserving surgery. Am J Surg 2006; 192(4):509–12PubMedCrossRef

57.

Van Goethem M, Tjalma W, Schelfout K, et al. Magnetic resonance imaging in breast cancer. Eur J Surg Oncol 2006; 32(9):901–10PubMedCrossRef

58.

Cassano E, Rizzo S, Bozzini A, et al. Contrast enhanced ultrasound of breast cancer. Cancer Imaging 2006; 6:4–6PubMedCrossRef

Titel: Intra-operative Sonography: A Valuable Aid During Breast-Conserving Surgery for Occult Breast Cancer
verfasst von: Anton Haid, MD
Michael Knauer, MD
Stephanie Dunzinger, MD
Zerina Jasarevic, MD
Roswitha Köberle-Wührer, MD
Antonius Schuster, MD
Michael Toeppker, MD
Bernhard Haid, MD
Etienne Wenzl, MD, FRCS
Felix Offner, MD
Publikationsdatum: 01.11.2007
Verlag: Springer-Verlag
Erschienen in: Annals of Surgical Oncology / Ausgabe 11/2007
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-007-9490-9

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2007

Clinical Implication of CXCL12 Expression in Gastric Cancer

Surgical Outcome of Intraductal Papillary Mucinous Neoplasms of the Pancreas

Plasminogen Activator System Localization in 60 Cases of Ductal Carcinoma In Situ

Para-Aortic Involvement and Interest of Para-Aortic Lymphadenectomy after Chemoradiation Therapy in Patients with Stage IB2 and II Cervical Carcinoma Radiologically Confined to the Pelvic Cavity

Genomic Instability and the Development of Metastatic Lymph Node Tumors

Transforming Growth Factor-β Binding Receptor Endoglin (CD105) Expression in Esophageal Cancer and in Adjacent Nontumorous Esophagus as Prognostic Predictor of Recurrence

Update Chirurgie